Michael Havert

Michael Havert, PhD |  SVP Regulatory Affairs

Michael Havert joined Nanoscope Therapeutics in January 2023 as Senior Vice President, Regulatory Affairs.  He brings nearly 20 years of experience across regulatory, quality and CMC aspects of cell and gene therapies both as a team member of several startups, and as a leader within the FDA. Previously, Michael has held senior executive positions in Regulatory Affairs at CBMG, StrideBio, and Bluebird Bio. Prior to that, Mike held positions of increasing responsibility within the FDA (CBER) including having served as BLA Review Chair, championing the release of guidance documents, and working toward global harmonization efforts.  Michael holds a PhD from the University of Wisconsin, Madison, and conducted postdoctoral fellowships in virology at JHU and NIH.

 

On February 2, 2023   /    
Nanoscope Therapeutics, Inc.
Trinity Towers
2777 N. Stemmons Fwy.
Dallas, TX 75207
(817) 857-1186

  • Dr. Samarendra Mohanty, PhD |  Co-Founder & President

    Samarendra Mohanty (Co-Founder/President) is an inventor & serial entrepreneur with 20+ years experience in Biomedical Sciences. He is Co-Founder of several Biotechs and Biomedical device /diagnostic companies (developed & commercialized $100K+ biomedical instruments.)

    Dr. Mohanty obtained M.Tech in Applied Optics from the Indian Institute of Technology-Delhi and a PhD in (Bio)Physics from the Indian Institute of Sciences-Bangalore.

    His extensive Biomedical Technologies experience includes serving as Professor/Senior Scientist at the University of Texas;  University of California, Irvine; Center for Adv. Tech (India); Int. Mol. Biotech (Germany); Univ. Pavia (Italy); NUS (Singapore); and University of St. Andrews (UK). He has authored over 200 international patents and publications in leading journals including Nature and Nature Photonics.

    He is the Principal Investigator for major grants from the National Eye Institute including Audacious Goal Initiative and Bioengineering Research grants. He serves on the editorial board of journals and chairs an international conference on optogenetics. He is the winner of a 2019 Healthcare Heroes award (Fort Worth Business Press), Retinal Organoid Challenge Award, Audacious Goal Initiative Award (NIH), Finalist of Tech Titan, and NIH-Director’s Innovator Award.